Intech Investment Management LLC lifted its position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 73.9% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 56,775 shares of the company's stock after purchasing an additional 24,125 shares during the quarter. Intech Investment Management LLC owned about 0.07% of HealthEquity worth $5,017,000 as of its most recent filing with the SEC.
Other institutional investors have also modified their holdings of the company. WPG Advisers LLC purchased a new stake in shares of HealthEquity during the 1st quarter worth about $28,000. Versant Capital Management Inc purchased a new stake in HealthEquity during the first quarter worth approximately $28,000. Northwestern Mutual Wealth Management Co. grew its stake in HealthEquity by 176.4% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 655 shares of the company's stock worth $58,000 after buying an additional 418 shares during the period. Larson Financial Group LLC boosted its position in HealthEquity by 1,366.0% during the 1st quarter. Larson Financial Group LLC now owns 689 shares of the company's stock worth $61,000 after purchasing an additional 642 shares during the period. Finally, BI Asset Management Fondsmaeglerselskab A S purchased a new stake in HealthEquity during the 1st quarter worth $65,000. Hedge funds and other institutional investors own 99.55% of the company's stock.
Analyst Upgrades and Downgrades
A number of analysts recently weighed in on HQY shares. Wall Street Zen raised shares of HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. Barrington Research reaffirmed an "outperform" rating and issued a $125.00 target price on shares of HealthEquity in a research report on Friday, August 29th. Jefferies Financial Group upped their target price on HealthEquity from $130.00 to $134.00 and gave the stock a "buy" rating in a research report on Wednesday, September 3rd. The Goldman Sachs Group upped their price target on HealthEquity from $94.00 to $104.00 and gave the stock a "neutral" rating in a report on Wednesday, June 4th. Finally, Bank of America upped their price target on HealthEquity from $110.00 to $125.00 and gave the stock a "buy" rating in a report on Wednesday, June 4th. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and one has issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Buy" and an average price target of $119.77.
View Our Latest Stock Analysis on HealthEquity
HealthEquity Stock Performance
HQY stock traded up $1.78 during mid-day trading on Thursday, reaching $94.06. The company had a trading volume of 370,999 shares, compared to its average volume of 1,033,322. The company has a quick ratio of 4.23, a current ratio of 4.23 and a debt-to-equity ratio of 0.47. The stock has a market capitalization of $8.10 billion, a P/E ratio of 57.00, a P/E/G ratio of 1.31 and a beta of 0.50. HealthEquity, Inc. has a one year low of $74.07 and a one year high of $116.65. The stock's 50-day simple moving average is $92.90 and its two-hundred day simple moving average is $94.19.
Insiders Place Their Bets
In related news, EVP Michael Henry Fiore sold 1,794 shares of HealthEquity stock in a transaction dated Monday, July 7th. The shares were sold at an average price of $101.73, for a total value of $182,503.62. Following the sale, the executive vice president directly owned 53,225 shares in the company, valued at $5,414,579.25. This trade represents a 3.26% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.50% of the stock is currently owned by corporate insiders.
HealthEquity Profile
(
Free Report)
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Stories
Before you consider HealthEquity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.
While HealthEquity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
